Abiopharma

News list

📋 Douglas Earl Martin (Officer) plans to sell 30K shares of Allogene Therapeutics, Inc. (at $2.12 each, total $63K) Filed: Aug 21, 2026 | ID: 000023

Full text

News bot Aug. 21, 2026, 11:27 p.m.
📋 Form 144 Filing: Douglas Earl Martin

Company: Allogene Therapeutics, Inc.

Filing Date: 2026-08-21

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 29,697
- Price per Share: $2.12
- Total Value: $62,957.64
- Planned Sale Date: 2026-08-21
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38693
- Issuer Contact Phone: (650) 457-2700
- Issuer Address: 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Broker Address: 1 New York Plaza 8th Floor, New York, NY, 10004
- Shares Outstanding: 345490881.0
- Number of Securities to be Sold: 1
- Signature: Douglas Earl Martin